Latest news with #ex-Boston
USA Today
2 days ago
- Sport
- USA Today
5 games to watch for from Celtics 2025-26 schedule
The 2025-26 regular season schedule is officially here, and the Boston Celtics will kick things off with a home game against the rival Philadelphia 76ers on Wednesday, October 22. Although Boston's prospects for next season aren't as promising as usual due to the untimely injury of Celtics star Jayson Tatum and a plethora of roster changes, there are still plenty of dates to look forward to. On December 5th, the C's will have a reunion of sorts at TD Garden with first-year Los Angeles Laker Marcus Smart, who went from being the heartbeat of the Celtics to a key member of their most-hated foe. Then, on January 10th, Boston will welcome the San Antonio Spurs and former Celtics center Luke Kornet. Exactly a week later, the C's will travel down south to visit the Atlanta Hawks, who now employ ex-Boston big man Kristaps Porzingis. Another reunion will be in the works in the new year on January 26th, when the Celtics host former starting guard Jrue Holiday and the Portland Trail Blazers. Last, but not least, the Green Team will face the Golden State Warriors on March 18th. This interconference contest will be particularly emotional if the rumors surrounding Celtics free agent Al Horford are true, as the NBA vet is expected to either retire or join the Dubs this offseason. December 5th, 2025 - vs. Los Angeles Lakers - 7:00 pm ET January 10th, 2026 - vs. San Antonio Spurs - 8:00 pm ET January 17th, 2026 - at Atlanta Hawks - 7:30 pm ET January 26th, 2026 - vs. Portland Trail Blazers - 8:00 pm ET March 18th, 2026 - vs. Golden State Warriors - 7:00 pm ET Listen to "Havlicek Stole the Pod" on: Spotify: iTunes: YouTube:
USA Today
3 days ago
- Sport
- USA Today
Today in Boston Celtics history: Barros signs, Brickowski, Atkins, Roberts, Kabengele born
Today in Boston Celtics history, point guard Dana Barros signed with the Celtics in 2004. It would be the last stop of his NBA career, one that spanned 14 seasons in total. It was not Barros first time playing with the Celtics, either, with the Boston College alum having previously suited up for the team for five seasons between 1995 and 2000. A native of Boston, Massachusetts, Barros would leave his hometown school to join the NBA when he was drafted by the Seattle SuperSonics with the 16th overall pick of the 1989 NBA draft. He would play for the Sonics and the Philadelphia 76ers before signing with Boston for the first time in 1995, and left the team when he was dealt to Dallas Mavericks in 2000. His second stint was much shorter, with Barros getting dealt to the Detroit Pistons just two months after signing with Boston for a second time. Birthdays It is the birthday of ex-Boston big man Frank Brickowski, born this day in 1959 in Bayville, New York. An alum of Penn State, Brickowski would also play for the Supersonics, Los Angeles Lakers, San Antonio Spurs, Milwaukee Bucks, and Charlotte Hornets before signing as a free agent with the Celtics in 1996. He averaged 4.8 points and 2 rebounds per game with the Celtics, retiring at the end of the 1996-97 season. Former Celtic point guard Chucky Atkins shares the birthday with Brickowski, born in 1974 in Orlando, Florida. Atkins played his NCAA ball at the University of South Florida and would play for the Orlando Magic and the Pistons before coming to Boston in a trade with Detroit. Atkins was with the Celtics for 24 games of the 2003-04 season, averaging 12 points, 1.9 rebounds, and 5.3 assists per game while with Boston. It is also the birthday of Boston big Fred Roberts, born in Provo, Utah, this day in 1960. A BYU alum, Roberts played for the Spurs and Utah Jazz, who traded him to the Celtics, where he would play two seasons. He averaged 5.8 points, 2.4 rebounds, and an assist per game with the team before being drafted by the Miami Heat in the 1988 NBA expansion draft. The pair share their birthday with former Celtics two way big man Mfiondu Kabengele. Born this day in Burlington, Ontario, Canada in 1997, Kabengele would play his NCAA ball for Florida State, and be drafted by the Brooklyn Nets with the 27th pick of the 2019 NBA draft before he was dealt to the Los Angeles Clippers. After playing short stints with the Cleveland Cavaliers and in the G League, the Canadian joined the Maine Celtics after a strong summer league. Rest in Peace It is also the day former Celtics guard Jack 'Dutch' Garfinkel passed away in 2013. An alum of St. John's University, Garfinkle would play in the rival American Basketball League (ABL) and National Basketball League (NBL — not to be confused with today's Australian league) before joining Boston in its inaugural campaign of 1946-47. He averaged 5.2 points and 1.5 assists per game while with the Celtics.
Yahoo
06-08-2025
- Business
- Yahoo
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions
Former FDA Director David Feigal joins Keyron as Head of Regulatory Affairs Dr Joyce Peetermans (ex-Boston Scientific) joins as Acting CTO Christopher Rowland (ex-Boston Scientific) appointed Chairman ForePass aims to replicate metabolic surgery without incisions Preparing for First-In-Human trials after strong large-animal data Head-to-head data showing superiority over $28B/year drug to be published soon LONDON & BOSTON, August 06, 2025--(BUSINESS WIRE)--Keyron, a pioneer in medical devices for advanced metabolic disease, today announced the appointment of three world-class leaders to its board of directors—including the former Director of the FDA's Center for Devices and Radiological Health (CDRH) and senior medtech industry leaders with key roles in notable exits within the endoscopy medical device sector. These appointments strengthen Keyron's regulatory, clinical, and strategic leadership as the company prepares for its upcoming clinical trials, associated global regulatory submissions, and future strategic alliances, centered around its ForePass device. ForePass is designed to replicate the outcomes of metabolic surgery—without cutting, puncturing, or trauma—through a fully reversible, minimally invasive procedure. Board Appointments David Feigal MD (Head of Regulatory Affairs) – Former Director of the FDA's Center for Devices and Radiological Health (CDRH). Covered the highest role and authority in medical devices at the FDA. Brings decades of experience guiding breakthrough technologies through FDA approval and will now be the Company's lead for FDA engagement and IDE submission. Founder of leading U.S. regulatory consultancy, NDA Partners. Widely recognized as one of the most experienced regulatory experts in the U.S., he has held senior global roles at public companies Amgen and Elan and led or advised over 20 successful medical product approvals across therapeutic areas. Joyce Peetermans, Ph.D. (Acting CTO) – 35+ years of leadership roles in R&D, Clinical Research, and Innovation in Gastroenterological and Surgical Endoscopy, and other specialties. She spent 25 years at Boston Scientific, where she was on the Endoscopy Management Board as VP of Global Clinical Programs, and VP of Innovation and Research during the $615M acquisition of Apollo Endosurgery and several other key acquisitions by Boston Scientific Endoscopy. Christopher Rowland (Chairman) – A seasoned executive with over 35 years leading Class III endoscopic and metabolic device companies. He served as President at Given Imaging prior to its $860M PillCam exit to Covidien (Medtronic) and was CEO of Neotract before its $1.1B acquisition by Teleflex. He also spent 17 years in senior roles at Boston Scientific. Christopher will chair Keyron's board of directors and support its corporate development and fundraising strategy. This leadership expansion follows several successful large-animal studies of ForePass demonstrating excellent safety, tolerability, and strong efficacy on both weight and insulin production. Key results were published in Gut (Angelini G, Galvao Neto M, Boskoski I, et al., 2024), showing ForePass's ability to replicate surgery-like results without incisions. The company is now preparing to unveil best-in-class preclinical data showing clear superiority over Semaglutide—the $28B/year standard of care for obesity and diabetes in Ozempic and Wegovy—across all major endpoints. These data are expected to be published this summer. 92% of Semaglutide patients fail to achieve 15% total body weight loss (New England Journal of Medicine, 2021; 385(6):503–515), with 85% discontinuing GLP-1 therapy within just 24 months (Reuters, 10 July 2024). Yet patients with severe obesity (BMI ≥35)—especially those who also have type 2 diabetes—need around 30% weight loss. Since GLP-1s fall substantially short and most stop taking them, surgery remains the only viable option, regularly delivering over 30% weight loss despite its risks and complications. ForePass is a fully removable, endoscopically implantable device aiming to replicate the metabolic benefits of surgery without incisions. It targets patients with BMI ≥35 and diabetes or BMI ≥40—a large, high-risk population underserved by current treatments. Giorgio Castagneto Gissey, Founder & CEO of Keyron, said: "Christopher, David, and Joyce are absolute world-class leaders. Their decision to join Keyron reflects the urgency of the metabolic crisis—especially the unmet need in diabetes and higher BMI—and the unique power of what we've built. Their expertise will be transformative as we enter human trials and deliver the first truly effective, scalable alternative to surgery for millions." Keyron, a VC-backed startup, has developed a proprietary biometabolic implant and endoscopic delivery system, secured leading clinical sites in the U.S. and internationally, and completed long-term preclinical validation. Full efficacy results—including head-to-head data versus Semaglutide in a porcine model—will be published shortly. The company is now preparing for its First-In-Human study. About Keyron Keyron is the first biometabolic device platform company, pioneering a new class of implantable therapies that aim to replicate the effects of bariatric and metabolic surgery without incisions—and restore metabolic health at its root without driving insulin overproduction or dependency. Headquartered in London and Boston, Keyron's mission is to deliver a scalable alternative to surgery—and a better option for patients with severe obesity and diabetes. See for more information. View source version on Contacts Media Contact Keyron Press Officepress@ London, UK and Boston, MA Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
24-07-2025
- Sport
- USA Today
On this day: M.L. Carr signs; Fox, Boykoff, Eliason born
On this day in Boston Celtics history, small forward M.L. Carr joined the Celtics for the second time as a free agent in 1979. The first time Carr signed with Boston was in 1974, and he did not make the team, instead choosing to go overseas to play in Israel. When that stint ended, he would link up with the American Basketball Association's (ABA) Spirit of St. Louis franchise. After the ABA merged with the NBA and the Spirit of St. Louis did not make the cut, Carr would join the Detroit Pistons under Dick Vitale, and then the Celtics afterward. "The whole country is looking for answers to the energy crisis; we found ours," said Boston coach Bill Fitch at the time (via the Washington Post's Ron Rosen). "This is a Carr that is energy efficient and gets plenty of miles to the gallon." Carr would play six seasons with the Celtics, averaging 6.3 points, 2.3 rebounds, and 1.3 assists per game with the Celtics, and would later coach and be the general manager of the team as well. It is also the birthday of former Celtic forward Rick Fox. Born in Toronto, Canada in 1969, Fox played his college ball with UNC and would be drafted by Boston 24th overall in the 1991 NBA Draft. He would play six seasons in the league before being released by the then-team president and head coach Rick Pitino in 1997 to make way for Pitino's vision of the team (a move in retrospect not held as one of the Celtics' best moments). Fox put up 10.7 points, 3.9 boards, and 2.8 assists per contest while with Boston. Fox shares that birthday with former Celtic center Harry Boykoff, who played 32 games with Boston in the 1950-51 season. Boykoff logged 6.3 points, 4.2 rebounds, and 1.3 assists per game in that short stretch. And as far as short stretches go, ex-Boston forward Don Eliason played just one game with the team in the Celtics' inaugural season of 1946-47, in which he registered 1 field goal attempt (it missed) and a personal foul. As brief a tenure as it was, it put Eliason in a very small club of players who have played in the NBA or its predecessor leagues (at this time it was still the Basketball Association of America or BAA) and NFL both. Providence College product Kevin Stacom left the team for the Indiana Pacers in free agency on this date in 1978. Stacom would later return for one more season in Boston and averaged 5.3 points, 1.5 rebounds, and as many assists in his time as a Celtic. Today is also the day we lost guard Sonny Hertzberg in 2005. The City College of New York standout played the last two seasons of his NBA career with the Celtics between 1949 and 1951, spanning the years the Basketball Association (BAA) became the NBA of today. He logged 10 points, 4 boards, and 3.3 assists per game while with Boston -- rest in peace. We also lost Celtics owner Richard Schmertz on this date in 1975. Schmertz, who also owned part of the Portland Trail Blazers and Hartford Whalers of NHL fame (now, the Carolina Hurricanes), had bought the team in 1972 from Irv Levin and Harold Lipton to become principal owner, only to see the team return to Levin and Lipton after successful litigation two years later. Schmertz would suffer a stroke on this date the following year, passing the same day -- rest in peace.
Time of India
23-07-2025
- Sport
- Time of India
Kyrie Irving makes a major revelation from his suspension days with Brooklyn Nets
Image via Getty Kyrie Irving revealed a major fact from his days of suspension. The player was suspended by the Brooklyn Nets for not taking the COVID-19 vaccine. Irving believed that it was his personal choice. He was free to do whatever he felt was right. The Nets, on the other hand, prohibited players without a vaccine from entering the home arena. Irving revealed that he had requested the Nets to let him go instead of just suspending him from the games. Kyrie Irving requested Brooklyn Nets to release him rather than just suspension In a recent appearance, Kyrie Irving opened up on his suspension. It was during his Brooklyn Nets days. Even though Irving was cleared for the away games, the player was not allowed to play the home games. Irving, on the other hand, was quite firm on his decision not to get vaccinated. A clip went viral that showcases a major fact from that incident. Kyrie Irving revealed the request that he had made to the Nets during his suspension. In the video, Irving stated, 'Even the people I was in business with were pro-vaccine. I was like, 'Okay, that's fine, but leave me the fuck out of this and let me go somewhere.'' He further continued, 'I even told the nets to release me. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo I said, 'Yo, can you just please release me?' I could obviously see the money situation. Different situation. I am f*cking Kyrie. I say that while being very aware of my position. They weren't just gonna let me rock out. Just go anywhere.' Why was Kyrie Irving suspended? Kyrie Irving was an asset for the Brooklyn Nets alongside Kevin Durant and James Harden. However, Irving had his own set of beliefs and hence refused to take the COVID shots. Owing to his decision, the player was banned from the home games. However, Irving was still allowed to play the away games. The General Manager of the Nets Sean Marks had issued a comment on it then. He stated, 'He has a choice to make and he made his choice. And my job here is to make what we deem is the best choices for the organization moving ahead and as a whole. They're not always ones that are going to be met with open arms and a thumbs up. These are hard decisions.' He further continued, 'And just like I'm sure it wasn't easy for Kyrie, either, to have to not be around his teammates.' Irving's rigid decision was criticized by fellow NBA mates like Raja Bell and Karl-Anthony Towns. FAQs When did Kyrie Irving sign with the Dallas Mavericks? Kyrie Irving signed with the Dallas Mavericks in 2023 Which position does Kyrie Irving play for? Kyrie Irving plays as the point guard for the Dallas Mavericks How many times was Kyrie Irving an NBA All-Star? Kyrie Irving became the NBA All-Star 9 times Also Read: NBA Trade Rumors: Golden State Warriors Predicted to Land $48 Million ex-Boston Celtics Star in Bold 3-Team Trade Proposal Catch Rani Rampal's inspiring story on Game On, Episode 4. Watch Here!
